<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=457360127799285&amp;ev=PageView&amp;noscript=1">

Therapeutic Areas



Chase Medical Research has conducts clinical trials for Nephrology in the areas of Chronic Kidney Disease, Diabetic Kidney Disease, and Chronic Kidney Disease with Anemia.

We participated in a clinical trial testing Kerendia (Finerenone) which was recently approved by the FDA. This medication improves kidney and heart outcomes in adults with chronic kidney disease associated with type 2 diabetes.


Center for Drug Evaluation and Research. “FDA Approves Drug for Chronic Kidney Disease.” U.S. Food and Drug Administration, FDA

Current Enrolling Studies

Learn more about the clinical trials that we are presently conducting or are about to begin.